Oligofructose
A short-chain prebiotic fiber (fructooligosaccharides, FOS) that provides mild sweetness and bulking. It ferments in the large intestine to feed beneficial bacteria.
Should I eat Oligofructose?
This is a refined, fast‑fermenting prebiotic fiber that can support a healthier microbiome at modest doses but often causes gas if you overshoot. If you have IBS or follow low‑FODMAP, favor products with little or no oligofructose, or space out small servings.
Summary
Oligofructose (also called FOS) is a short‑chain, soluble fiber from chicory that is either hydrolyzed from inulin or enzymatically built from sucrose and then purified. It feeds beneficial gut bacteria and can gently soften stools, but the trade‑off is gas and bloating that rise with dose. Many people do fine at 5–10 g per day; symptoms climb above ~15 g/day, and sensitive guts may react sooner. Major safety reviews find no genotoxic or carcinogenic concerns; the real‑world limit is digestive comfort. Infant formulas use it only under specific approvals and caps—stick to labeled products for infants.
Key Research Points
Overview
What is it?
Why is it used?
Origin
Oligofructose belongs to the inulin-type fructans found naturally in plants like chicory and Jerusalem artichoke. Industrial production scaled in Europe in the 1980s–1990s (notably in Belgium) as companies learned to extract inulin from chicory and either hydrolyze it to shorter chains or build short fructose chains directly from sucrose using microbial fructosyltransferase enzymes. As evidence accumulated that FOS selectively stimulates bifidobacteria, it was commercialized globally as a prebiotic fiber for foods and, in limited amounts, formula applications.
Process: Hydrolyze inulin or enzymatically build FOS; then refine and dry
Steps
Chemicals
Research & Safety
Potential Concerns
The main concern is digestive discomfort—gas, bloating, cramps, or loose stools—which tends to increase with dose. People with IBS or FODMAP sensitivity often react to small amounts of fructans, so individualized limits are important. For infants, only use products specifically formulated and approved to contain inulin/oligofructose; do not add it separately. There is no evidence of mutagenicity or carcinogenicity in standard test systems used in regulatory safety assessments, so systemic toxicity is not a practical concern at food‑use levels.
Potential Benefits
Oligofructose selectively feeds bifidobacteria at modest daily doses (about 5–10 g), supporting a healthier gut microbiome. It adds soluble fiber with mild sweetness and only ~1.5–2 kcal/g, helping reduce added sugars while keeping good texture in foods. Some studies show softer stools or slightly increased frequency, but results vary across trials and brands. Regulatory reviews (e.g., EFSA) recognize FOS as non‑digestible carbohydrate/fiber, yet approved wording for specific health claims is conservative.
Digestive Effects
In healthy adults, many tolerate 10–15 g/day without major issues, but symptoms become more common at 15–30 g/day; a minority can tolerate higher intakes after gradual increases. Sensitive individuals (especially with IBS or on low‑FODMAP diets) may experience symptoms at 5–10 g/day. Typical symptoms include gas, bloating, abdominal discomfort, and sometimes looser stools due to rapid fermentation. To improve comfort, split doses with meals, increase gradually over 1–2 weeks, and pair with fluids.
Limit Consumption
Infants should only consume oligofructose when it is included in a labeled infant formula that has been reviewed for that use and at the specified level. People with IBS are more likely to react to fructans; blinded reintroduction trials identify fructans as common triggers, so tailored limits are recommended. Those with small intestinal bacterial overgrowth (SIBO) or significant GI disorders may also be more sensitive and should introduce prebiotic fibers cautiously. No major allergenicity concerns are reported for purified oligofructose.
Fact Sheet
Regulatory Status
ESG & Sustainability
Allergens and Diet
Natural Alternatives
Inulin
Resistant dextrin
Soluble corn fiber
Citations
Agency Response Letter GRAS Notice No. GRN 000605 (Fructo-oligosaccharides)
2018-03-28FDA CFSAN • FDA
GRAS Notice 605 PDF – Fructo-oligosaccharides (technical details)
2018-03-28FDA CFSAN • FDA
GRAS Notice GRN 576 – Inulin/Oligofructose for certain infant formulas
2015-12-09FDA CFSAN • FDA
GRAS Notice 1006 – Short-chain FOS (safety compilation)
2021-12-16FDA CFSAN • FDA
Gastrointestinal Tolerance of Short-Chain Fructo-Oligosaccharides in Healthy Adults
2022-04-01Le Bourgot C., et al. • Nutrients
Tolerance of oligofructose at 15–30 g/d and effects on stool characteristics
2014-07-01François I.E.J.A., et al. • British Journal of Nutrition (open via PMC)
Inulin/Oligofructose Technical Report (NOSB background)
2015-01-20USDA Agricultural Marketing Service • USDA-AMS
Scientific Opinion on non-digestible oligo- and polysaccharides and health claims
2014-11-19EFSA NDA Panel • EFSA Journal
Prebiotic Type Spotlight: Fructooligosaccharides (FOS)
2023-08-01GPA • Global Prebiotic Association
Gastrointestinal Tolerance of Chicory Inulin Products
2010-06-01Bonnema A.L., et al. • Journal of the American Dietetic Association